We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012–2021.
- Authors
Yang, Seonkyeong; Huang, Shu; Hincapie-Castillo, Juan M.; Ke, Xuehua; Ding, Helen; Schelfhout, Jonathan; Sher, Mandel R.; Jones, Bobby; Wilson, Debbie L.; Lo-Ciganic, Wei-Hsuan
- Abstract
Among patients with chronic cough (CC) in the 2012–2021 statewide OneFlorida Clinical Research Consortium database, we examined trends in cough medication (CM) prescribing prevalence over time in repeated cross-sectional analyses and identified distinct CM utilization trajectories using group-based trajectory modeling (GBTM) in a retrospective cohort study. Among eligible adults (≥18 years) without cancer/benign respiratory tumor diagnoses, we identified CC patients and non-CC patients with any cough-related diagnosis. In the GBTM analysis, we calculated the number of monthly prescriptions for any CMs (excluding gabapentinoids) during the 12 months from the first qualifying cough event to identify distinct utilization trajectories. From 2012 to 2021, benzonatate (9.6% to 26.1%), dextromethorphan (5.2% to 8.6%), and gabapentinoid (5.3% to 14.4%) use increased among CC patients, while opioid antitussive use increased from 2012 to 2015 and decreased thereafter (8.4% in 2012, 14.7% in 2015, 6.7% in 2021; all p < 0.001). Of 15,566 CC patients and 655,250 non-CC patients identified in the GBTM analysis, CC patients had substantial burdens of respiratory/non-respiratory comorbidities and healthcare service and concomitant medication use compared to non-CC patients. Among CC patients, GBTM identified three distinct CM utilization trajectories: (1) no CM use (n = 11,222; 72.1%); (2) declining CM use (n = 4105; 26.4%); and (3) chronic CM use (n = 239; 1.5%). CC patients in Florida had limited CM use with increasing trends in use of benzonatate, dextromethorphan, and gabapentinoids and a decreasing trend in opioid antitussive use. CC patients, particularly with chronic prescription CM use, experienced substantial disease burden.
- Subjects
FLORIDA; CHRONIC cough; DRUGS; MEDICAL research; CONSORTIA; TUMOR diagnosis; DATABASES
- Publication
Journal of Clinical Medicine, 2023, Vol 12, Issue 19, p6286
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm12196286